Send Inquiry

Request To Call Back

Pamorelin La 11.25mg Injection

Name: Pamorelin La 11.25mg Injection
Brand: Maheshwari Medical Agency
Price: 12500 INR
Availability: InStock

Price 12500 INR/ Unit

Get a Price/Quote

MOQ : 1 Unit

Pamorelin La 11.25mg Injection Specification

Indication
Prostate cancer, endometriosis, uterine fibroids

Brand Name
Pamorelin LA

Life Span
36 months from the date of manufacture

Dosage Form
Long-acting suspension for injection

Packaging Type
Vial with diluent for suspension

Salt Composition
Triptorelin Pamoate

Pacakaging (Quantity Per Box)
1 Injection per box

Origin of Medicine
Imported

Drug Type
Prescription medicine

Ingredients
Triptorelin Pamoate 11.25 mg

Physical Form
Injection

Function
Gonadotropin-releasing hormone (GnRH) analogue

Recommended For
Prostate cancer, endometriosis, and other hormone-related conditions

Dosage
As directed by the physician

Dosage Guidelines
Intramuscular injection every 3 months, or as prescribed

Suitable For
Adults

Quantity
1 Vial

Storage Instructions
Store below 25C, protect from light

Handling Precautions
For hospital/institutional use only

Shelf Life After Reconstitution
Use immediately after reconstitution

Type of Release
Sustained/Long-acting release

Reconstitution Instructions
Reconstitute powder with supplied diluent prior to injection

Registration Status
Registered under CDSCO India

Prescription Status
To be sold by retail on the prescription of a registered medical practitioner only

Colour
White to off-white lyophilized powder

Trade Name
Pamorelin LA 11.25 mg

Therapeutic Class
Hormone therapy

Diluent Included
Yes, sterile water for injection

Strength
11.25 mg per vial

Route of Administration
Intramuscular

Marketed By
Debiopharm International SA

Pamorelin La 11.25mg Injection Trade Information

Minimum Order Quantity
1 Unit

Supply Ability
100 Units Per Week

Delivery Time
7 Days

About Pamorelin La 11.25mg Injection

Discover the latest advancement in hormone therapy with Pamorelin LA 11.25 mg Injection. Specially formulated for sustained, long-acting release, this astonishing solution contains Triptorelin Pamoate 11.25 mg per vial for intramuscular use. Championing patient wellbeing, it's marketed by Debiopharm International SA and registered under CDSCO India, ensuring both quality and authenticity. Capitalise on its spectacular reliability for conditions such as prostate cancer, endometriosis, and uterine fibroids. Each box includes a lyophilized powder and sterile water diluent, guaranteeing precise preparation. Store below 25C and use immediately post reconstitution.

Key Features & Surface Applications

Pamorelin LA 11.25mg Injection is designed for hospital or institutional use, offering an outstanding long-acting hormone therapy solution, ideal for adults with prostate cancer, endometriosis, or uterine fibroids. Intended for intramuscular administration, the spectacular formulation ensures consistent therapeutic results over three months. The medication is supplied as a white to off-white lyophilized powder with a sterile water diluent, allowing for optimal absorption and effectiveness at the designated muscle site. Follow all handling and application guidelines for best outcomes.

Payment Terms & Certifications: Seamless Process

Pamorelin LA 11.25mg Injection is available for distributors, suppliers, and traders in India's export market. Payment outlay terms are flexible and secure, supporting a streamlined procurement process. Certified and registered under CDSCO India, this product carries dependable quality and compliance credentials. Reliable transport services ensure secure and timely delivery, while a sample policy is available on request to facilitate confident purchases and export activities. Your trust and satisfaction are integral to our service commitment.

FAQ's of Pamorelin La 11.25mg Injection:

Q: How is Pamorelin LA 11.25mg Injection administered?

A: Pamorelin LA 11.25mg Injection is administered as an intramuscular injection by a qualified healthcare professional, every three months or as directed by a physician.

Q: What are the primary benefits of choosing Pamorelin LA 11.25mg Injection?

A: This medicine provides sustained, long-acting hormone therapy, offering reliable management for prostate cancer, endometriosis, and uterine fibroids, reducing the need for frequent dosing.

Q: When should Pamorelin LA 11.25mg Injection be used after reconstitution?

A: The injection should be used immediately after reconstitution with the supplied sterile water for injection to ensure effectiveness and safety.

Q: Where should Pamorelin LA 11.25mg be stored before use?

A: Store the product in a dry, cool place, below 25C, and protect it from light to maintain its stability before preparation and administration.

Q: What is the process for preparing Pamorelin LA 11.25mg Injection?

A: Reconstitute the lyophilized powder with the provided sterile diluent by following the included instructions, then administer intramuscularly immediately after preparation.

Tell us about your requirement